Asthma Treatment: Buteyko Breathing Technique

NCT07105306 | Completed

• 1 other identifier: EGE-ASHYM-SBİ-01
• Study Type: interventional
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to evaluate the effects of BBT training on asthma control, quality of life, and pulmonary function among asthma patients.The findings suggest that BBT may be a potentially effective complementary approach. However, given the small sample size and short follow-up duration, larger studies with longer-term follow-up are necessary to confirm and generalize these results.

Conditions

Asthma

Keywords

Asthma; Buteyko; complementary therap

Outcome Measures

Primary Outcomes (1)

• Change in Asthma Control

  Asthma control will be assessed using the Asthma Control Questionnaire (ACQ-6). Higher scores indicate worse control. Scores range from 5 to 25, with lower scores indicating better asthma control. The original Cronbach's alpha was reported as 0.85; in this study, the internal consistency was calculated as 0.88.

  Baseline to 6 months after intervention

Study Arms (2)

Buteyko Breathing Training Group

EXPERIMENTAL

Participants in this group will receive a structured training program on the Buteyko breathing technique, consisting of weekly sessions over 6 months. The intervention aims to improve respiratory function and reduce asthma symptoms through controlled breathing exercises.

Other: Buteyko Breathing Technique Training

Control Group

NO INTERVENTION

Standard Care

Interventions

Buteyko Breathing Technique Training OTHER

Buteyko Breathing Technique (BBT), developed in the 1950s, which focuses on reducing dysfunctional hyperventilation patterns through breath control and extended breath-holding phases called control pauses

Buteyko Breathing Training Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• were followed in the asthma outpatient clinic of the university hospital,
• had stable asthma (no exacerbation in the last 6 weeks),
• had no communication problems,
• had no history of smoking,
• were using inhaled corticosteroids regularly (without dose changes in the past 4 weeks),
• voluntarily agreed to participate in the study.

You may not qualify if:

• presence of another chronic pulmonary disease (e.g., COPD, bronchiectasis),
• psychiatric illness history or use of psychiatric medications,
• cognitive impairment or inability to follow instructions,
• pregnancy or breastfeeding,
• participation in another clinical trial simultaneously.

Sponsors & Collaborators

• Seçil Beyece İncazli: lead

Study Sites (1)

Ege University

Izmir, İzmir, 35040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Lecturer (PhD), Vocational School of Health Services

Model Details: randomized controlled trial

Study Record Dates

• First Submitted: July 17, 2025
• First Posted: August 5, 2025
• Study Start: June 1, 2018
• Primary Completion: June 1, 2018
• Study Completion: June 3, 2019
• Last Updated: August 5, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)